Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
iSTAR Medical
This is a prospective, multicenter, masked clinical trial to evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.
Age
46–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males and females, 46 years of age or older
A diagnosis of primary open-angle glaucoma, who are candidates for medical therapy, laser treatment, or glaucoma-filtering surgery
Pseudophakic with prior uncomplicated cataract surgery
You may not be if
Angle closure, congenital, or secondary glaucoma
Diagnosed degenerative visual disorders
Clinically significant intraocular inflammation or infection
Clareo Health | Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
